HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
October 22-24, 2026 | Boston, Massachusetts, USA
PHE 2026

Bioethics challenges in public health

Speaker at Public Health Conferences - Miroslav Radenkovic
University of Belgrade, Serbia
Title : Bioethics challenges in public health

Abstract:

Bioethics in public health involves balancing individual rights with collective well-being, often under resource constraints and urgent crises. Key challenges arise when promoting population health conflicts with personal autonomy or equity. Public health officials must navigate this by prioritizing proportionality, evidence, and transparency to justify any restrictions. To begin, public health measures like mandatory vaccinations or quarantines raise ethical tensions between community protection and individual consent. Historical cases, such as unethical experiments in Guatemala and Tuskegee, highlight risks of prioritizing research over participant welfare. Moreover, deciding who receives limited resources, such as ventilators during pandemics or vaccines in shortages, pits utilitarian goals against fairness principles. Strategies must avoid discrimination while maximizing overall benefit, as explored in case studies on public health planning. To continue, contact tracing and data collection for disease control challenge confidentiality rights. Ethical frameworks urge minimizing intrusion while ensuring data security to build public trust. Finally, low-resource settings face disparities in access to technologies or treatments, compounded by varying cultural norms. Bioethics calls for collaborative governance to prevent exploitation in research and ensure equitable outcomes from scientific advances. To summarize, mandatory interventions, resource allocation, privacy vs. surveillance and global equity issues represent some of the most important bioethics challenges in public health that are going to be further evaluated.

Biography:

Miroslav Radenković, MD, MS, PhD, a full-time professor at the Department of Pharmacology, Clinical Pharmacology and Toxicology, graduated from the Faculty of Medicine: University of Belgrade (FMUB) in 1995, and from 1996 he is working at the FMUB. He received an MS from pharmacology, board certified in Clinical Pharmacology, PhD from Medical Sciences, and a sub-specialization degree in Clinical Pharmacology: Pharmacotherapy in 1999, 2000, 2004, and 2016 respectively, from the FMUB, as well as Bioethics MS in 2021 from the Clarkson University, NYC, USA. From 2002 Dr. Radenković officially participated in several scientific projects supported by the Ministry of Science: Serbia; the Austrian Science Fund; Cost Action; as well as the NIH Fogarty International Center Project, USA. He is a member of the Ethics Board of Serbia and a Chair Department.

Youtube
Watsapp